Misoprostol: Is it Significantly Reduced in Our Waste Streams?

Yes, misoprostol is generally removed or significantly reduced during conventional wastewater treatment, though specific peer-reviewed data on it is very limited compared to more commonly studied pharmaceuticals.

[Note: Misoprostol is a medicine that protects the stomach lining and also causes the uterus to contract. It’s used for stomach ulcers, medication abortion, miscarriage management, and to help stop heavy bleeding after childbirth. Mifepristone and misoprostol are two medications commonly used together in medication abortion (also called the “abortion pill”) to end an early pregnancy. They are also used for managing early pregnancy loss (miscarriage).]

Key Points on Removal / Management of Misoprostol in Waste Streams

• Conventional treatment (primary + secondary activated sludge + sedimentation): Many pharmaceuticals like misoprostol are partially removed through sorption to sludge (binding to solids) and some biodegradation. However, standard wastewater treatment plants are not specifically designed to remove trace pharmaceuticals, so some portion can pass through and it is clear it can accumulate in the sludge.
  
  
• Misoprostol-specific characteristics:
  
  
  • It is rapidly metabolized in the body to misoprostol acid (active form), which further breaks down into inactive metabolites.
    
    
  • It has low persistence and is not highly stable in aqueous environments (degrades with moisture).
    
    
  • Safety Data Sheets (Pfizer and others) indicate no harmful effects expected to aquatic organisms at relevant concentrations, and low overall environmental concern.
    
    
• Advanced treatment (ozonation, activated carbon, membranes): These are highly effective (>90–95% removal for many pharmaceuticals) and would remove any remaining misoprostol or its metabolites.

Real-World Context

• Misoprostol is used in much lower volumes than many other drugs (e.g., antibiotics, painkillers, hormones), so influent concentrations are extremely low (likely ng/L or below detection in most plants).
  
  
• No widespread detections of misoprostol in treated wastewater effluents are reported in major monitoring studies. Environmental risk is considered negligible.
  
  
• Like mifepristone, any trace amounts that might reach surface water are far below levels that cause toxicity to aquatic life (acute toxicity data show effects only at mg/L concentrations — millions of times higher than environmental levels).

What “Significantly Reduced” Means

“Significantly reduced” in the context of wastewater treatment for pharmaceuticals like misoprostol typically refers to removal efficiencies of 70–95% or higher in conventional treatment plants, though exact percentages vary by compound, plant design, and conditions.

• High removal (“significantly reduced”): >80–95%
  
  
• Moderate removal: 50–80%
  
  
• Low or variable removal: <50% (or even “negative removal” where effluent concentrations are higher due to deconjugation of metabolites).

For misoprostol specifically, there are no widely published, compound-specific removal percentages from full-scale wastewater treatment plants (WWTPs) in peer-reviewed literature. However, based on its chemical properties (rapid degradation, sorption potential, and similarity to other prostaglandins/steroids), it is expected to fall into the moderately to highly removed category through conventional activated sludge systems.

Why Removal Varies

• Primary treatment (settling): Removes some via sorption to solids (often 20–60%).
  
  
• Secondary treatment (activated sludge): Main removal step for many organics — often achieves 60–90%+ for degradable or sorbing compounds.
  
  
• Overall plant efficiency: Many modern WWTPs achieve >85–95% total removal for compounds with properties similar to misoprostol.

Bottom line: When experts say “significantly reduced,” they generally mean the compound is reduced by at least 70–90% (often much higher in practice) before discharge, leaving only trace residuals that are further diluted in rivers. This is why environmental risk from misoprostol is considered negligible. Advanced treatments (ozone, activated carbon) can push removal above 95–99%. Claims suggesting it routinely passes through untreated are not supported by evidence, but land application of sludges and management of water and wastewater sludges may be an issue that should be investigated.

Special Case: Rural Areas with Septic Systems

This article focuses on conventional municipal wastewater treatment. Septic systems typically achieve lower and more variable removal of pharmaceuticals than modern treatment plants. While absolute environmental concentrations of misoprostol (or its metabolites) remain extremely low due to limited usage and rapid degradation, individuals on septic systems should be aware that residuals may reach groundwater or surface water with less attenuation.

Septic systems are primarily designed for the treatment of domestic wastewater generated from household activities, such as bathing, cooking, and toilet use. They consist of a septic tank and a drainfield, which work together to treat and disperse wastewater safely into the environment. Septic systems are not designed to handle postpartum tissue or miscarriages.

We would recommend that this chemical not be used for patients that rely on septic systems and that the patient should be treated at a medical facility with the appropriate systems. In summary, septic systems should not be used for disposing of postpartum tissue or miscarriages, and appropriate medical disposal methods should be followed instead.

Here are 4 reliable web pages related to misoprostol (and the mifepristone/misoprostol regimen) in wastewater treatment and environmental fate:

1. FDA Environmental Assessment for Mifepristone (2000)
   https://www.accessdata.fda.gov/drugsatfda_docs/nda/2000/20687_Mifepristone_EA.pdf
   (Official FDA document covering the combination regimen including misoprostol; assesses excretion, environmental entry, and concludes no significant impact after wastewater treatment.)
   
   
2. FDA General Guidance on Environmental Assessments for Human Drugs
   https://www.fda.gov/media/70809/download
   (Broader FDA framework used for evaluating how drugs like misoprostol are removed or behave in wastewater treatment plants.)
   
   
3. Pfizer Misoprostol Safety Data Sheet (Environmental Fate Section)
   https://cdn.pfizer.com/pfizercom/products/material_safety_data/PZ00195.pdf
   (Manufacturer SDS with information on environmental persistence, aquatic toxicity, and implied low concern after treatment.)
   
   
4. EPA: How Pharmaceuticals Enter the Environment
   https://www.epa.gov/household-medication-disposal/how-pharmaceuticals-enter-environment
   (General EPA overview explaining that conventional wastewater treatment removes some but not all pharmaceuticals; applies to low-volume drugs like misoprostol.)

Note: There are no highly specific peer-reviewed studies focused solely on misoprostol removal rates in WWTPs (unlike more common drugs). It is assessed under general pharmaceutical guidelines, with very low expected concentrations and negligible risk.